5 min listen
JACC: Advances - Nirmatrelvir-Ritonavir for Acute Covid-19 in Patients with Cardiovascular Disease and Post-Acute Sequelae of SARS-CoV-2-Infection
JACC: Advances - Nirmatrelvir-Ritonavir for Acute Covid-19 in Patients with Cardiovascular Disease and Post-Acute Sequelae of SARS-CoV-2-Infection
ratings:
Length:
3 minutes
Released:
Jun 26, 2024
Format:
Podcast episode
Description
Commentary by Dr. Candice Silversides
Released:
Jun 26, 2024
Format:
Podcast episode
Titles in the series (100)
Mexiletine in LQTS and TdP: Commentary by Dr. David Wilber by JACC Specialty Journals